Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiform...
Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme
About this item
Full title
Author / Creator
Publisher
American Society for Clinical Investigation
Journal title
Language
English
Formats
Publication information
Publisher
American Society for Clinical Investigation
Subjects
More information
Scope and Contents
Contents
TRIAL REGISTRATION. anzctr.org.au: ACTRN12615000656538.
Alternative Titles
Full title
Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A641057642
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A641057642
Other Identifiers
ISSN
0021-9738
DOI
10.1172/JCI138649